Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials
1998

Assessing Health in Breast Cancer Patients

Sample size: 84 publication Evidence: high

Author Information

Author(s): C Hurny, B van Wegberg, M Bacchi, J Bernhard, B Thurlimann, O Real, L Perey, H Bonnefoi, A Coates

Primary Institution: University Hospital Insel, Bern, Switzerland

Hypothesis

We aimed to develop and validate a simple linear analogue self-assessment scale to assess utility values in breast cancer trials.

Conclusion

The SHE scale is a valid and feasible method to assess the value patients attribute to their current state of health.

Supporting Evidence

  • The SHE scale was preferred by most patients over the SHED scale.
  • SHE scores were significantly different based on treatment type and time since diagnosis.
  • Older patients had lower mean SHE scores compared to younger patients.
  • The two LASA scales showed a strong correlation (r = 0.8).
  • Patients found the SHE scale easier to understand than the SHED scale.

Takeaway

Doctors wanted to find an easy way for breast cancer patients to rate their health, and they found a method that many patients liked.

Methodology

Patients completed two LASA scales and a time trade-off interview to assess their health state.

Potential Biases

Patients may have had biases in their self-assessment due to emotional factors.

Limitations

The study was limited to patients from three language areas in Switzerland.

Participant Demographics

{"age_distribution":{"45 and younger":19,"46-55":27,"56-65":24,"66 and older":14},"performance_status":{"0":39,"1":28,"2-3":17},"nodal_status":{"positive":64,"negative":16,"unknown":4},"ER_status":{"positive":53,"negative":16,"unknown":15},"first_diagnosis":{"within_last_2_years":11,"within_last_5_years":36,">_5_years":26,">_10_years":11},"first_recurrence":{"within_last_6_months":17,"within_last_2_years":30,">_2_years":37},"chemotherapy_at_interview_time":{"none":36,"mild":15,"intensive":33}}

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI -0.1 to 9.3

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication